Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Elder

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cancer Biology & Therapy|August 25, 2006
Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cellsTianqian Zhang, Rajasekharan Somasundaram, Carola Berking, et al.
Journal of Pharmaceutical Sciences|October 28, 2017
Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and CommercializationHaiyan Grady, David Elder, Gregory K Webster, et al.
Cancer Research|April 19, 2007
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage displayRolf K Swoboda, Rajasekharan Somasundaram, Laura Caputo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2024
Banff 2022 Vascularized Composite Allotransplantation Meeting Report: Diagnostic criteria for vascular changesLinda C Cendales, Alton B Farris, Ivy Rosales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxelKeith T Flaherty, Joan Schiller, Lynn M Schuchter, et al.
BMJ Open|January 14, 2025
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised studyZhuohan Wu, Brooke Nickel, Farzaneh Boroumand, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2008
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)Mark Harland, Alisa M Goldstein, Kairen Kukalizch, et al.
Regulatory Toxicology and Pharmacology : RTP|August 21, 2017
A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategiesChris Barber, Vincent Antonucci, Jens-Christoph Baumann, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
18-month outcomes of heterologous bilateral hand transplantation in a child: a case reportSandra Amaral, Sudha Kilaru Kessler, Todd J Levy, et al.
Histopathology|November 20, 2025
WHO classification of skin tumours: key updates in the fifth editionGabrielle Goldman-Lévy, Raymond Barnhill, Boris C Bastian, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Biology & Therapy|August 25, 2006
Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cellsTianqian Zhang, Rajasekharan Somasundaram, Carola Berking, et al.
Journal of Pharmaceutical Sciences|October 28, 2017
Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and CommercializationHaiyan Grady, David Elder, Gregory K Webster, et al.
Cancer Research|April 19, 2007
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage displayRolf K Swoboda, Rajasekharan Somasundaram, Laura Caputo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2024
Banff 2022 Vascularized Composite Allotransplantation Meeting Report: Diagnostic criteria for vascular changesLinda C Cendales, Alton B Farris, Ivy Rosales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxelKeith T Flaherty, Joan Schiller, Lynn M Schuchter, et al.
BMJ Open|January 14, 2025
Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised studyZhuohan Wu, Brooke Nickel, Farzaneh Boroumand, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2008
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)Mark Harland, Alisa M Goldstein, Kairen Kukalizch, et al.
Regulatory Toxicology and Pharmacology : RTP|August 21, 2017
A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategiesChris Barber, Vincent Antonucci, Jens-Christoph Baumann, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
18-month outcomes of heterologous bilateral hand transplantation in a child: a case reportSandra Amaral, Sudha Kilaru Kessler, Todd J Levy, et al.
Histopathology|November 20, 2025
WHO classification of skin tumours: key updates in the fifth editionGabrielle Goldman-Lévy, Raymond Barnhill, Boris C Bastian, et al.
Pageof 4